{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:41:31Z","timestamp":1786981291189,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T00:00:00Z","timestamp":1726099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32AR076951"],"award-info":[{"award-number":["T32AR076951"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["T32AR076951"],"award-info":[{"award-number":["T32AR076951"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR083424"],"award-info":[{"award-number":["R01AR083424"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The RK Mellon Institute for Pediatric Research"},{"name":"The Childhood Arthritis and Rheumatology Research Alliance"},{"name":"National Institute of Child Health and Human Development","award":["R01HD098428"],"award-info":[{"award-number":["R01HD098428"]}]},{"name":"National Institute of Child Health and Human Development","award":["R01HD098428"],"award-info":[{"award-number":["R01HD098428"]}]},{"name":"National Institute of Child Health and Human Development","award":["R01HD098428"],"award-info":[{"award-number":["R01HD098428"]}]},{"name":"SickKids Clinician Scientist Training Program scholarship"},{"name":"Children\u2019s Hospital of Philadelphia, Immune Dysregulation Frontiers Program"},{"DOI":"10.13039\/100002136","name":"Histiocytosis Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002136","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Paul Calabresi K12 Career Development Award","award":["5K12CA076931-24"],"award-info":[{"award-number":["5K12CA076931-24"]}]},{"name":"Canadian Institute for Health Research (CIHR) Fellowship Award"},{"name":"Alex\u2019s Lemonade Stand Fund (ALSF) \u2018A\u2019 Award"},{"name":"IpiNovyx"},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["K23GM148827-01"],"award-info":[{"award-number":["K23GM148827-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>High ferritin is an important and sensitive biomarker for the various forms of hemophagocytic lymphohistiocytosis (HLH), a diverse and deadly group of cytokine storm syndromes. Early action to prevent immunopathology in HLH often includes empiric immunomodulation, which can complicate etiologic work-up and prevent collection of early\/pre-treatment research samples. To address this, we instituted an alert system at UPMC Children\u2019s Hospital where serum ferritin\u2009&gt;\u20091000\u00a0ng\/mL triggered real-time chart review, assessment of whether the value reflected \u201cinflammatory hyperferritnemia (IHF)\u201d, and biobanking of remnant samples from consenting IHF patients. We extracted relevant clinical data; periodically measured serum total IL-18, IL-18 binding protein (IL-18BP), and CXCL9; retrospectively classified patients by etiology into infectious, rheumatic, or immune dysregulation; and subjected a subgroup of samples to a 96-analyte biomarker screen. 180 patients were identified, 30.5% of which had IHF. Maximum ferritin levels were significantly higher in patients with IHF than with either hemoglobinopathy or transplant, and highly elevated total IL-18 levels were distinctive to patients with Stills Disease and\/or Macrophage Activation Syndrome (MAS). Multi-analyte analysis showed elevation in proteins associated with cytotoxic lymphocytes in all IHF samples when compared to healthy controls and depression of proteins such as ANGPT1 and VEGFR2 in samples from hyperferritinemic sepsis patients relative to non-sepsis controls. This real-time IFH screen proved feasible and efficient, validated prior observations about the specificity of IL-18, enabled early sample collection from a complex population, suggested a unique vascular biomarker signature in hyperferritinemic sepsis, and expanded our understanding of IHF heterogeneity.<\/jats:p>","DOI":"10.1007\/s10875-024-01797-4","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T14:06:41Z","timestamp":1726495601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Hyperferritinemia Screening to Aid Identification and Differentiation of Patients with Hyperinflammatory Disorders"],"prefix":"10.1007","volume":"45","author":[{"given":"Hallie A.","family":"Carol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam S.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinh","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jemy","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Tsoukas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy Q.","family":"Cron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Diorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren A.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Schulert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pui","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate F.","family":"Kernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott W.","family":"Canna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,12]]},"reference":[{"issue":"8","key":"1797_CR1","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10067-012-1998-0","volume":"31","author":"CI Lin","year":"2012","unstructured":"Lin CI, Yu HH, Lee JH, Wang LC, Lin YT, Yang YH, et al. Clinical analysis of macrophage activation syndrome in pediatric patients with autoimmune diseases. Clin Rheumatol. 2012;31(8):1223\u201330.","journal-title":"Clin Rheumatol"},{"key":"1797_CR2","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1146\/annurev-med-061813-012806","volume":"66","author":"GS Schulert","year":"2015","unstructured":"Schulert GS, Grom AA. Pathogenesis of macrophage activation syndrome and potential for cytokine- directed therapies. Annu Rev Med. 2015;66:145\u201359.","journal-title":"Annu Rev Med"},{"issue":"5","key":"1797_CR3","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1136\/adc.85.5.421","volume":"85","author":"S Sawhney","year":"2001","unstructured":"Sawhney S, Woo P, Murray KJ. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child. 2001;85(5):421\u20136.","journal-title":"Arch Dis Child"},{"issue":"5","key":"1797_CR4","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.jaci.2020.09.016","volume":"146","author":"SW Canna","year":"2020","unstructured":"Canna SW, Cron RQ. Highways to hell: Mechanism-based management of cytokine storm syndromes. J Allergy Clin Immunol. 2020;146(5):949\u201359.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1797_CR5","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/pbc.21039","volume":"48","author":"JI Henter","year":"2007","unstructured":"Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124\u201331.","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"1797_CR6","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.39332","volume":"68","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a european league against rheumatism\/american college of rheumatology\/paediatric rheumatology international trials organisation collaborative initiative. Arthritis Rheumatol. 2016;68(3):566\u201376.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"1797_CR7","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1002\/art.38690","volume":"66","author":"L Fardet","year":"2014","unstructured":"Fardet L, Galicier L, Lambotte O, Marzac C, Aumont C, Chahwan D, et al. Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol. 2014;66(9):2613\u201320.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"1797_CR8","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1002\/art.42636","volume":"75","author":"B Shakoory","year":"2023","unstructured":"Shakoory B, Geerlinks A, Wilejto M, Kernan K, Hines M, Romano M, et al. The 2022 EULAR\/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis\/Macrophage Activation Syndrome (HLH\/MAS). Arthritis Rheumatol. 2023;75(10):1714\u201332.","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"1797_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxx031","volume":"29","author":"KF Kernan","year":"2017","unstructured":"Kernan KF, Carcillo JA. Hyperferritinemia and inflammation. Int Immunol. 2017;29(9):401\u20139.","journal-title":"Int Immunol"},{"issue":"7","key":"1797_CR10","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/0009922819837352","volume":"58","author":"CM Horvat","year":"2019","unstructured":"Horvat CM, Bell J, Kantawala S, Au AK, Clark RSB, Carcillo JA. C-reactive protein and ferritin are associated with organ dysfunction and mortality in hospitalized children. Clin Pediatr (Phila). 2019;58(7):752\u201360.","journal-title":"Clin Pediatr (Phila)"},{"issue":"13","key":"1797_CR11","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood-2017-12-820852","volume":"131","author":"ES Weiss","year":"2018","unstructured":"Weiss ES, Girard-Guyonvarc\u2019h C, Holzinger D, de Jesus AA, Tariq Z, Picarsic J, et al. Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome. Blood. 2018;131(13):1442\u201355.","journal-title":"Blood"},{"issue":"19","key":"1797_CR12","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","volume":"382","author":"F Locatelli","year":"2020","unstructured":"Locatelli F, Jordan MB, Allen C, Cesaro S, Rizzari C, Rao A, et al. Emapalumab in children with primary hemophagocytic lymphohistiocytosis. N Engl J Med. 2020;382(19):1811\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"1797_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1136\/annrheumdis-2015-209020","volume":"76","author":"C Bracaglia","year":"2017","unstructured":"Bracaglia C, de Graaf K, PiresMarafon D, Guilhot F, Ferlin W, Prencipe G, et al. Elevated circulating levels of interferon-gamma and interferon-gamma-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. Ann Rheum Dis. 2017;76(1):166\u201372.","journal-title":"Ann Rheum Dis"},{"key":"1797_CR14","doi-asserted-by":"publisher","unstructured":"Segal JE, Daley JD, Barnum JL, Salgado CM, Reyes-Mugica M, Schneider C, et al. Systemic and nodular hyperinflammation in a patient with refractory familial hemophagocytic lymphohistiocytosis 2. J Clin Immunol. 2021;https:\/\/doi.org\/10.1007\/s10875-021-00986-9","DOI":"10.1007\/s10875-021-00986-9"},{"issue":"1","key":"1797_CR15","doi-asserted-by":"publisher","first-page":"e000161","DOI":"10.1136\/rmdopen-2015-000161","volume":"2","author":"A Ravelli","year":"2016","unstructured":"Ravelli A, Minoia F, Davi S, Horne A, Bovis F, Pistorio A, et al. Expert consensus on dynamics of laboratory tests for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. RMD Open. 2016;2(1):e000161.","journal-title":"RMD Open"},{"issue":"10","key":"1797_CR16","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1093\/clinchem\/46.10.1719","volume":"46","author":"AW Butch","year":"2000","unstructured":"Butch AW. Dilution protocols for detection of hook effects\/prozone phenomenon. Clin Chem. 2000;46(10):1719\u201321.","journal-title":"Clin Chem"},{"issue":"7","key":"1797_CR17","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1002\/art.42099","volume":"74","author":"G Chen","year":"2022","unstructured":"Chen G, Deutsch GH, Schulert GS, Zheng H, Jang S, Trapnell B, et al. Identification of distinct inflammatory programs and biomarkers in systemic juvenile idiopathic arthritis and related lung disease by serum proteome analysis. Arthritis Rheumatol. 2022;74(7):1271\u201383.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"1797_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1002\/acr2.11048","volume":"1","author":"EMA Eloseily","year":"2019","unstructured":"Eloseily EMA, Minoia F, Crayne CB, Beukelman T, Ravelli A, Cron RQ. Ferritin to erythrocyte sedimentation rate ratio: simple measure to identify macrophage activation syndrome in systemic juvenile idiopathic arthritis. ACR Open Rheumatol. 2019;1(6):345\u20139.","journal-title":"ACR Open Rheumatol"},{"issue":"4","key":"1797_CR19","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/CCM.0000000000004131","volume":"48","author":"G Lachmann","year":"2020","unstructured":"Lachmann G, Knaak C, Vorderwulbecke G, La Rosee P, Balzer F, Schenk T, et al. Hyperferritinemia in critically Ill patients. Crit Care Med. 2020;48(4):459\u201365.","journal-title":"Crit Care Med"},{"issue":"10","key":"1797_CR20","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1007\/s00277-017-3072-0","volume":"96","author":"ZK Otrock","year":"2017","unstructured":"Otrock ZK, Hock KG, Riley SB, de Witte T, Eby CS, Scott MG. Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis. Ann Hematol. 2017;96(10):1667\u201372.","journal-title":"Ann Hematol"},{"issue":"2","key":"1797_CR21","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s12185-015-1813-1","volume":"102","author":"H Saeed","year":"2015","unstructured":"Saeed H, Woods RR, Lester J, Herzig R, Gul Z, Monohan G. Evaluating the optimal serum ferritin level to identify hemophagocytic lymphohistiocytosis in the critical care setting. Int J Hematol. 2015;102(2):195\u20139.","journal-title":"Int J Hematol"},{"issue":"3","key":"1797_CR22","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/PCC.0b013e3181a1ae08","volume":"10","author":"L Castillo","year":"2009","unstructured":"Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis\/ systemic inflammatory response syndrome\/multiorgan dysfunction syndrome\/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med. 2009;10(3):387\u201392.","journal-title":"Pediatr Crit Care Med"},{"issue":"1","key":"1797_CR23","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13054-022-03977-3","volume":"26","author":"Y Qin","year":"2022","unstructured":"Qin Y, Kernan KF, Fan Z, Park HJ, Kim S, Canna SW, et al. Machine learning derivation of four computable 24-h pediatric sepsis phenotypes to facilitate enrollment in early personalized anti-inflammatory clinical trials. Crit Care. 2022;26(1):128.","journal-title":"Crit Care"},{"issue":"6","key":"1797_CR24","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/pbc.21423","volume":"50","author":"CE Allen","year":"2008","unstructured":"Allen CE, Yu X, Kozinetz CA, McClain KL. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008;50(6):1227\u201335.","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"1797_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1097\/RHU.0b013e31829ce01f","volume":"19","author":"C Moore Jr","year":"2013","unstructured":"Moore C Jr, Ormseth M, Fuchs H. Causes and significance of markedly elevated serum ferritin levels in an academic medical center. J Clin Rheumatol. 2013;19(6):324\u20138.","journal-title":"J Clin Rheumatol"},{"issue":"2","key":"1797_CR26","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/cei.13543","volume":"203","author":"JM Krei","year":"2021","unstructured":"Krei JM, Moller HJ, Larsen JB. The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis\/macrophage activation syndrome - a systematic review. Clin Exp Immunol. 2021;203(2):174\u201382.","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"1797_CR27","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1093\/rheumatology\/keab113","volume":"60","author":"T Hinze","year":"2021","unstructured":"Hinze T, Kessel C, Hinze CH, Seibert J, Gram H, Foell D. A dysregulated interleukin-18\/interferon-gamma\/CXCL9 axis impacts treatment response to canakinumab in systemic juvenile idiopathic arthritis. Rheumatology (Oxford). 2021;60(11):5165\u201374.","journal-title":"Rheumatology (Oxford)."},{"issue":"6","key":"1797_CR28","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jpeds.2012.11.081","volume":"162","author":"K Lehmberg","year":"2013","unstructured":"Lehmberg K, Pink I, Eulenburg C, Beutel K, Maul-Pavicic A, Janka G. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis. J Pediatr. 2013;162(6):1245\u201351.","journal-title":"J Pediatr"},{"issue":"9","key":"1797_CR29","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.3899\/jrheum.211219","volume":"49","author":"ML Taylor","year":"2022","unstructured":"Taylor ML, Hoyt KJ, Han J, Benson L, Case S, Chandler MT, et al. An Evidence-based guideline improves outcomes for patients with hemophagocytic lymphohistiocytosis and macrophage activation syndrome. J Rheumatol. 2022;49(9):1042\u201351.","journal-title":"J Rheumatol"},{"issue":"17","key":"1797_CR30","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1182\/bloodadvances.2021004287","volume":"5","author":"H Lin","year":"2021","unstructured":"Lin H, Scull BP, Goldberg BR, Abhyankar HA, Eckstein OE, Zinn DJ, et al. IFN-gamma signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS. Blood Adv. 2021;5(17):3457\u201367.","journal-title":"Blood Adv"},{"issue":"2","key":"1797_CR31","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, et al. Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase III trial. Crit Care Med. 2016;44(2):275\u201381.","journal-title":"Crit Care Med"},{"issue":"1","key":"1797_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12916-017-0930-5","volume":"15","author":"E Kyriazopoulou","year":"2017","unstructured":"Kyriazopoulou E, Leventogiannis K, Norrby-Teglund A, Dimopoulos G, Pantazi A, Orfanos SE, et al. Macrophage activation-like syndrome: an immunological entity associated with rapid progression to death in sepsis. BMC Med. 2017;15(1):172.","journal-title":"BMC Med"},{"key":"1797_CR33","doi-asserted-by":"publisher","unstructured":"Kyriazopoulou E, Panagopoulos P, Metallidis S, Dalekos GN, Poulakou G, Gatselis N, et al. An open label trial of anakinra to prevent respiratory failure in COVID-19. Elife. 2021;10. https:\/\/doi.org\/10.7554\/eLife.66125","DOI":"10.7554\/eLife.66125"},{"issue":"1","key":"1797_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40635-022-00433-y","volume":"10","author":"RR Anderko","year":"2022","unstructured":"Anderko RR, Gomez H, Canna SW, Shakoory B, Angus DC, Yealy DM, et al. Sepsis with liver dysfunction and coagulopathy predicts an inflammatory pattern of macrophage activation. Intensiv Care Med Exp. 2022;10(1):6.","journal-title":"Intensiv Care Med Exp"},{"issue":"1","key":"1797_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12014-022-09389-3","volume":"19","author":"LR Van Nynatten","year":"2022","unstructured":"Van Nynatten LR, Slessarev M, Martin CM, Leligdowicz A, Miller MR, Patel MA, et al. Novel plasma protein biomarkers from critically ill sepsis patients. Clin Proteomics. 2022;19(1):50.","journal-title":"Clin Proteomics"},{"issue":"6","key":"1797_CR36","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/SHK.0000000000000903","volume":"48","author":"R Zonneveld","year":"2017","unstructured":"Zonneveld R, Jongman R, Juliana A, Zijlmans W, Plotz F, Molema G, et al. Low serum Angiopoietin-1, high serum Angiopoietin-2, and high Ang-2\/Ang-1 protein ratio are associated with early onset sepsis in surinamese newborns. Shock. 2017;48(6):638\u201343.","journal-title":"Shock"},{"issue":"12","key":"1797_CR37","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.it.2006.10.004","volume":"27","author":"U Fiedler","year":"2006","unstructured":"Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006;27(12):552\u20138.","journal-title":"Trends Immunol"},{"issue":"6","key":"1797_CR38","doi-asserted-by":"publisher","first-page":"517","DOI":"10.4161\/viru.24906","volume":"4","author":"SM Parikh","year":"2013","unstructured":"Parikh SM. Dysregulation of the angiopoietin-Tie-2 axis in sepsis and ARDS. Virulence. 2013;4(6):517\u201324.","journal-title":"Virulence"},{"key":"1797_CR39","doi-asserted-by":"publisher","first-page":"155029","DOI":"10.1016\/j.cyto.2020.155029","volume":"129","author":"CH Seol","year":"2020","unstructured":"Seol CH, Yong SH, Shin JH, Lee SH, Leem AY, Park MS, et al. The ratio of plasma angiopoietin-2 to angiopoietin-1 as a prognostic biomarker in patients with sepsis. Cytokine. 2020;129:155029.","journal-title":"Cytokine"},{"key":"1797_CR40","first-page":"200","volume":"395","author":"RB Lindell","year":"2024","unstructured":"Lindell RB, Sayed S, Campos JS, Knight M, Mauracher AA, Hay CA, et al. Dysregulated STAT3 signaling and T cell immunometabolic dysfunction define a targetable, high mortality subphenotype of critically ill children. medRxiv. 2024;395:200.","journal-title":"medRxiv."},{"issue":"5","key":"1797_CR41","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1002\/(SICI)1096-911X(199705)28:5<342::AID-MPO3>3.0.CO;2-H","volume":"28","author":"JI Henter","year":"1997","unstructured":"Henter JI, Aric\u00f2 M, Egeler RM, Elinder G, Favara BE, Filipovich AH, et al. HLH-94: a treatment protocol for hemophagocytic lymphohistiocytosis. HLH study Group of the Histiocyte Society. Med Pediatr Oncol. 1997;28(5):342\u20137.","journal-title":"Med Pediatr Oncol."},{"key":"1797_CR42","doi-asserted-by":"publisher","first-page":"4700","DOI":"10.1182\/blood-2004-12-4935","volume":"105","author":"I Voskoboinik","year":"2005","unstructured":"Voskoboinik I, Thia M-C, Trapani JA. A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood J. 2005;105:4700\u20136.","journal-title":"Blood J"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01797-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-024-01797-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-024-01797-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T15:46:53Z","timestamp":1777304813000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-024-01797-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,12]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1797"],"URL":"https:\/\/doi.org\/10.1007\/s10875-024-01797-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4523502\/v1","asserted-by":"object"}]},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,12]]},"assertion":[{"value":"3 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"4"}}